XENE
Xenon Pharmaceuticals Inc. · Healthcare
President and CEO Ian Mortimer sold $404K of Xenon Pharmaceuticals Inc.
Sold$403,584
$55.23Price
7,308Shares
−18%Stake
What XENE did after the filing
- The stock from Mon, Mar 16 open, $55.00
- −0.9%
- S&P 500, same days
- +6.5%
Measured over 30 trading days, to the Apr 28 close.
Traded Fri, Mar 13. Filed Fri, Mar 13, 4:16 PM ET, after the close. Returns use the Mar 16 open and the Apr 28 close. Not investment advice.